• Canadian Critical Care Trials Group
    The Canadian Critical Care Trials Group (CCCTG) is a highly collegial group that is dedicated to the pursuit of excellence and advancement of critical care research in Canada.
  • Canadian Critical Care Trials Group
    The CCCTG has are more than 30 research programs underway and over 100 peer-reviewed publications to its credit, with direct impact on clinical practice in critical care.
  • Canadian Critical Care Trials Group
    The Canadian Critical Care Trials Group (CCCTG) is a national organization of more than 300 individuals with research interests in the management of the critically ill patient.
  • Canadian Critical Care Trials Group
    Endorsement by the CCCTG communicates our full commitment to ensure that the work is undertaken in a rigorous and ethical manner, and communicated in a timely and effective way.
Coordinates

Institution

Hamilton Health Sciences

City

Hamilton

Contact This Member

Alison Fox-Robichaud

Dr. Fox-Robichaud is Professor in the Division of Critical Care, Department of Medicine in the Faculty of Health Sciences at McMaster University.

Dr. Fox-Robichaud is Professor in the Division of Critical Care, Department of Medicine in the Faculty of Health Sciences at McMaster University and an Intensivist and Director of Medical Education at Hamilton Health Sciences (HHS). In addition to her clinical training in Ottawa (MD) and Calgary (Internal Medicine and Critical Care) she has an undergraduate degree in Biology and Chemistry from the University of New Brunswick, a MSc in Medical Sciences (GI physiology) from McMaster University and she completed postdoctoral training at the University of Calgary.
A clinician scientist in the Thrombosis and Atherosclerosis Research Institute at McMaster, Dr. Fox-Robichaud is particularly interested in the pathophysiology of sepsis and in moving laboratory research discoveries into clinical care. She currently holds a Collaborative Health Research Program grant to develop a point of care device for the sepsis biomarker cell free DNA.
In addition to her clinical and research responsibilities, Dr. Fox-Robichaud is an educator and national leader in CCM. She is the current President of the Canadian Critical Care Society and inaugural President of the Canadian Sepsis Foundation. She is an executive member of the Canadian Critical Care Translational Biology Group and the Canadian Critical Care Trials Group. She is the Past chair of the Critical Care Medicine examination board at the Royal College of Physicians and Surgeons of Canada. Her teaching interests include in continuing education in critical care, simulation and interprofessional teams. In 2015, she received a Leading Practice Award from Accreditation Canada for the integration of an electronic early warning score into the medical documentation at Hamilton Health Sciences. She has over 60 peer-reviewed publications that reflect this broad engagement in academic medicine.